264 related articles for article (PubMed ID: 8111066)
1. Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface.
Braaten JV; Jerome WG; Hantgan RR
Blood; 1994 Feb; 83(4):982-93. PubMed ID: 8111066
[TBL] [Abstract][Full Text] [Related]
2. Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus.
Braaten JV; Handt S; Jerome WG; Kirkpatrick J; Lewis JC; Hantgan RR
Blood; 1993 Mar; 81(5):1290-9. PubMed ID: 8443390
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of c7E3 Fab on thrombus formation and rt-PA-Mediated thrombolysis under flow conditions.
Huang TC; Jordan RE; Hantgan RR; Alevriadou BR
Thromb Res; 2001 Jun; 102(5):411-25. PubMed ID: 11395127
[TBL] [Abstract][Full Text] [Related]
4. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction.
Kunitada S; FitzGerald GA; Fitzgerald DJ
Blood; 1992 Mar; 79(6):1420-7. PubMed ID: 1547340
[TBL] [Abstract][Full Text] [Related]
6. A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots.
Collet JP; Montalescot G; Lesty C; Weisel JW
Circ Res; 2002 Mar; 90(4):428-34. PubMed ID: 11884372
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.
Torr-Brown SR; Sobel BE
Thromb Res; 1993 Dec; 72(5):413-21. PubMed ID: 8303684
[TBL] [Abstract][Full Text] [Related]
8. Effect of chemical conjugation of recombinant single-chain urokinase-type plasminogen activator with monoclonal antiplatelet antibodies on platelet aggregation and on plasma clot lysis in vitro and in vivo.
Dewerchin M; Lijnen HR; Stassen JM; De Cock F; Quertermous T; Ginsberg MH; Plow EF; Collen D
Blood; 1991 Aug; 78(4):1005-18. PubMed ID: 1831057
[TBL] [Abstract][Full Text] [Related]
9. Real-time measurement of lysis of mural platelet deposits by fibrinolytic agents under arterial flow.
Graham DA; Huang TC; Keyt BA; Alevriadou BR
Ann Biomed Eng; 1998; 26(4):712-24. PubMed ID: 9662163
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinases regulate the cytoskeletal attachment of integrin alpha IIb beta 3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin polymers.
Schoenwaelder SM; Jackson SP; Yuan Y; Teasdale MS; Salem HH; Mitchell CA
J Biol Chem; 1994 Dec; 269(51):32479-87. PubMed ID: 7798249
[TBL] [Abstract][Full Text] [Related]
11. The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood.
Carrieri C; Galasso R; Semeraro F; Ammollo CT; Semeraro N; Colucci M
J Thromb Haemost; 2011 Jan; 9(1):154-62. PubMed ID: 20961395
[TBL] [Abstract][Full Text] [Related]
12. Platelets and endothelial cells act in concert to delay thrombolysis--evidence from an in vitro model of the human occlusive thrombus.
Hantgan RR; Jerome WG; Handt S
Thromb Haemost; 1998 Mar; 79(3):602-8. PubMed ID: 9531049
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.
Whyte CS; Swieringa F; Mastenbroek TG; Lionikiene AS; Lancé MD; van der Meijden PE; Heemskerk JW; Mutch NJ
Blood; 2015 Apr; 125(16):2568-78. PubMed ID: 25712989
[TBL] [Abstract][Full Text] [Related]
14. Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis.
Collet JP; Montalescot G; Lesty C; Soria J; Mishal Z; Thomas D; Soria C
Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):142-8. PubMed ID: 11145946
[TBL] [Abstract][Full Text] [Related]
15. Altered plasma fibrin clot properties in essential thrombocythemia.
Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
[TBL] [Abstract][Full Text] [Related]
16. The significance of fibrin binding by plasminogen activator inhibitor 1 for the mechanism of tissue-type plasminogen activator-mediated fibrinolysis.
Stringer HA; Pannekoek H
J Biol Chem; 1995 May; 270(19):11205-8. PubMed ID: 7744752
[TBL] [Abstract][Full Text] [Related]
17. Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis.
Meh DA; Mosesson MW; DiOrio JP; Siebenlist KR; Hernandez I; Amrani DL; Stojanovich L
Blood Coagul Fibrinolysis; 2001 Dec; 12(8):627-37. PubMed ID: 11734662
[TBL] [Abstract][Full Text] [Related]
18. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
[TBL] [Abstract][Full Text] [Related]
19. Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms.
Fay WP; Eitzman DT; Shapiro AD; Madison EL; Ginsburg D
Blood; 1994 Jan; 83(2):351-6. PubMed ID: 8286735
[TBL] [Abstract][Full Text] [Related]
20. Microfluidic Modeling of Thrombolysis.
Loyau S; Ho-Tin-Noé B; Bourrienne MC; Boulaftali Y; Jandrot-Perrus M
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2626-2637. PubMed ID: 30354249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
